NASA proposes asteroid redirect mission with ion engine 20 times more powerful than recent Dawn mission

NASA has a proposed asteroid redirect mission which would use an ion propulsion that is 20 times bigger than the recent Dawn mission to Ceres and Vesta.

NASA is developing a first-ever robotic mission to visit a large near-Earth asteroid, collect a multi-ton boulder from its surface, and redirect it into a stable orbit around the moon. Once it’s there, astronauts will explore it and return with samples in the 2020s. This Asteroid Redirect Mission (ARM) is part of NASA’s plan to advance the new technologies and spaceflight experience needed for a human mission to the Martian system in the 2030s.

NASA has identified multiple candidate asteroids and continues the search for one that could be redirected to near the moon in the 2020s. Since the announcement of the Asteroid Initiative in 2013, NASA’s Near-Earth Object Observation Program has catalogued more than 1,000 new near-Earth asteroids discovered by various search teams. Of those identified so far, four could be good candidates for ARM. Scientists anticipate many more will be discovered over the next few years, and NASA will study their velocity, orbit, size and spin before deciding on the target asteroid for the ARM mission.

The Asteroid Redirect Mission is one part of NASA’s Asteroid Initiative. The initiative also includes an Asteroid Grand Challenge, designed to accelerate NASA’s efforts to locate potentially hazardous asteroids through non-traditional collaborations and partnerships. The challenge could also help identify viable candidates for ARM.

NASA plans to launch the ARM robotic spacecraft at the end of this decade. The spacecraft will capture a boulder off of a large asteroid using a robotic arm. After an asteroid mass is collected, the spacecraft will redirect it to a stable orbit around the moon called a “Distant Retrograde Orbit.” Astronauts aboard NASA’s Orion spacecraft, launched from a Space Launch System (SLS) rocket, will explore the asteroid in the mid-2020s.